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Abstract
Background: Female chronic pelvic pain (CPP) is defined as intermittent or constant pelvic or lower abdominal pain occurring
in a woman for at least 6 months. Up to a quarter of women are estimated to be affected by CPP worldwide and it is responsible
for one fifth of specialist gynecological referrals in the United Kingdom. Psychological interventions are commonly utilized. As
waiting times and funding capacity impede access to face-to-face consultations, supported self-management (SSM) has emerged
as a viable alternative. Mindfulness meditation is a potentially valuable SSM tool, and in the era of mobile technology, this can
be delivered to the individual user via a smartphone app.
Objective: To assess the feasibility of conducting a trial of a mindfulness meditation intervention delivered by a mobile phone
app for patients with CPP. The main feasibility objectives were to assess patient recruitment and app adherence, to obtain
information to be used in the sample size estimate of a future trial, and to receive feedback on usability of the app.
Methods: Mindfulness Meditation for Women With Chronic Pelvic Pain (MEMPHIS) is a three-arm feasibility trial, that took
place in two hospitals in the United Kingdom. Eligible participants were randomized in a 1:1:1 ratio to one of three treatment
arms: (1) the intervention arm, consisting of a guided, spoken mindfulness meditation app; (2) an active control arm, consisting
of a progressive muscle relaxation app; and (3) usual care (no app). Participants were followed-up for 6 months. Key feasibility
outcomes included the time taken to recruit all patients for the study, adherence, and estimates to be used in the sample size
calculation for a subsequent full-scale trial. Upon completion of the feasibility trial we will conduct focus groups to explore app
usability and reasons for noncompliance.
Results: Recruitment for MEMPHIS took place between May 2016 and September 2016. The study was closed March 2017
and the report was submitted to the NIHR on October 26, 2017.
Conclusions: This feasibility trial will inform the design of a large multicentered trial to assess the clinical effectiveness of
mindfulness meditation delivered via a smartphone app for the treatment of CPP.
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Introduction
Female chronic pelvic pain (CPP) is defined as intermittent or
constant pain in the lower abdomen or pelvis of a woman for
at least 6 months, which is not exclusively associated with
menstruation or intercourse, and not associated with pregnancy
[1]. CPP affects up to 24% of women worldwide [2], accounts
for 20% of gynecological clinic referrals in the United Kingdom
[3], and has a considerable impact on patients’ quality of life
and their income. There are no recent estimates of the cost of
CPP, but endometriosis-associated pain alone costs the United
Kingdom economy £8.2 billion per year in treatment, loss of
work, and health care costs [4], so the cost of general CPP is
likely to be even higher. Despite costly interventions, CPP is
often resistant to surgical and medical treatment. Both
psychosocial causes (such as a history of sexual abuse) and
somatic causes (eg, endometriosis, pelvic inflammatory disease,
bladder pain syndrome) can contribute to CPP [1]. High levels
of depression and anxiety are commonly associated with CPP,
but are often not addressed in this population [5].
These multifactorial causes require a multidimensional approach,
which is not routinely offered in gynecology clinics [6].
Evidence from randomized controlled trials (RCTs) suggests
that a holistic approach using psychological interventions may
be superior to primary surgery [7]. Although psychological
treatment is provided across the National Health Service (NHS),
mostly in the context of the primary care program Improving
Access to Psychological Therapies, there are problems with
capacity, waiting times, and the overall number of patients that
are able to access services. Alternatively, supported
self-management (SSM) is now recognized as a tool that
empowers patients to better cope with their condition [8].
Mindfulness-based therapy is currently creating lively research
interest. Two recent systematic reviews report positive effects
on somatization disorders [9] and psychological stress [10]. A
further systematic review carried out by our research team [11],
which examined 15 RCTs for online mindfulness meditation,
found small but significant beneficial impacts on depression,
anxiety, well-being, and mindfulness, and a moderate effect on
stress, with guided programs proving more effective than
unguided ones. We are only aware of one ongoing randomized
Danish study of mindfulness in patients with
endometriosis-specific CPP (NCT02761382).
Our review also found that mindfulness meditation to treat CPP
had a promising effect on patient well-being [11], as
demonstrated in pilot studies on CPP and larger RCTs on other
types of chronic pain. We are therefore investigating the
feasibility of a full RCT for mindfulness in CPP, as mindfulness
has great potential as a self-management tool that could be used
as part of a holistic approach to CPP.
More convenient delivery methods have been called for as an
alternative to the 8-week face-to-face sessions required for the
standard mindfulness based stress reduction (MBSR) courses
[12]. During a patient and public involvement (PPI) session we
held to help design our study, CPP patients expressed a
preference for receiving the intervention through a smartphone
app, as it is portable and could be accessed when and where
they liked.
The systematic review showed that mindfulness meditation
helps chronic pain patients accept pain better and helps to
alleviate anxiety and depression [11], which are particularly
common in this population [5]. One of the suggested
mechanisms of mindfulness meditation is the uncoupling of
sensory aspects from the evaluative and emotional aspects of
pain through mindful awareness and meditation. Unlike
cognitive behavioral therapy, which is goal oriented,
mindfulness meditation relies on nonjudgmental observation.
By distancing themselves from painful sensations and thoughts,
instead of being alarmed, patients can achieve greater acceptance
of chronic pain rather than permanently wanting to control it.
Systematic Review
Our systematic search and review of the literature on
mindfulness meditation in CPP (July 2013; updated May 2017)
was designed to investigate prior research in the area before
commencing our study. Our systematic review was conducted
in line with current standards [13]. We searched MEDLINE
(via OVID), EMBASE, PsychINFO, and AMED without
language restrictions from database inception to July 2013, and
subsequently updated the search in May 2017. The databases
were searched for relevant studies using the following key words
and word variants: chronic pain or pelvic pain, and meditation
or mindfulness or Vipanassa or mindfulness based stress
reduction or mindfulness based intervention or mindfulness
based therapy. The reference lists from the obtained articles
were examined for additional articles. We also hand-searched
all relevant systematic reviews and, if necessary, we approached
the authors for missing relevant information.
The first search identified two small, nonrandomized pilot trials
investigating the effect of mindfulness meditation on pelvic
pain (n=22) [14], and endometriosis (n=10) in particular [15].
Both small studies were uncontrolled. In the study on CPP,
significantly improved scores were reported for daily maximum
pain, physical function, mental health (P=.01), and social
function [14]. The mindfulness scores improved significantly
in all measures [14]. In endometriosis patients, significant
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improvements were reported for bodily pain, general health,
and vitality [15].
Since that time, two more studies have been published. Kanter
et al investigated the effect of mindfulness compared to usual
care in an RCT of patients with bladder pain syndrome (n=20)
[16]. Outcome measures relating to empowerment and
self-management improved significantly [16]. A small pilot
study on military women with CPP (n=15) showed a
nonsignificant reduction in pain and increase in mindfulness
measures [12]. The authors of this study called for simpler
formats of teaching mindfulness than the 8-week standard
MBSR, which four studies used [12].
Given this paucity of data on mindfulness in CPP, we expanded
our systematic review of mindfulness meditation to include its
use in other chronic pain conditions (back pain, headaches,
fibromyalgia, and diabetic neuropathy), as we assumed that any
benefits in these conditions might also be seen in CPP. Previous
systematic reviews of these conditions had a number of
limitations, such as not reporting effect sizes [17-19].
We identified 534 relevant citations, and 9 RCTs [20-28] were
included in the review [11]. Most studies were of moderate
quality, but sample sizes were generally small (from 65 to 259
women). Our results showed mindfulness-based meditation
reduced depression levels in chronic pain patients (standardized
mean difference [SMD] -0.31; 95% CI -0.52 to -0.10; I2=0%)
and anxiety (SMD -0.21; 95% CI -0.45 to 0.03; I2=0%). Pain
acceptance was also improved (SMD 0.34; 95% CI 0.09-0.59).
No significant changes were seen in quality of life, anxiety, pain
scores, or the emotional response to pain.
There are few published robust trials of apps to assist better
self-management of chronic conditions. A Cochrane review of
apps for asthma found only two studies and concluded there
was insufficient evidence to advise patients on their usefulness
[29]. Although CPP is as common as back pain and asthma [30],
there are no RCTs that are investigating mindfulness meditation
in CPP. Mindfulness meditation had shown a promising effect
on patient well-being in uncontrolled pilot studies on CPP and
larger RCTs on other types of chronic pain [11]. Given the high
levels of depression and anxiety in CPP patients, combined with
difficult access to psychological treatments, this approach could
address a gap both in knowledge and patient care.
Development of the Mindfulness Meditation App
Module
Headspace [31], a company that had already developed and
successfully established a mindfulness meditation app, was
approached to develop a module for meditation for chronic pain.
This module was incorporated into the existing library of app
content. The pain module can be accessed after participants
have completed the 10-day foundation program.
Aims and Objectives
The overall aim of this study is to assess the feasibility of
implementing a full scale, multicenter RCT to test the efficacy
of a mindfulness meditation intervention delivered by a mobile
phone app for patients with CPP. The primary objectives are:
(1) to provide feasibility data for a large multicenter RCT aimed
at rigorously testing mindfulness meditation in patients with
CPP (the full-scale trial will assess the effectiveness of the
mindfulness meditation app in patients with CPP in a national
multicenter RCT); and (2) to determine whether this app can




Mindfulness Meditation for Women With Chronic Pelvic Pain
(MEMPHIS) is a three-arm randomized feasibility trial.
Approval was received by Camden and Kings Cross Ethics
Committee in February 2016 (15/LO/1967).
Inclusion Criteria
To be eligible for the MEMPHIS study, women were required
to meet the following criteria: (1) aged 18 years or over; (2)
have organic and nonorganic CPP lasting for 6 months or more;
(3) be capable of understanding the information provided, and
be able to understand simple English as is used in the app; and
(4) give written informed consent.
Exclusion Criteria
Patients who met the following criteria were ineligible to
participate: (1) no access to a personal computer or smartphone,
or (2) current users of the Headspace app content available to
the public.
Study Design
MEMPHIS is a three-arm randomized feasibility trial. All
eligible women referred to the CPP clinics at the Royal London
and Whipps Cross Hospitals (both new and existing patients)
were approached to take part in the study. The setting of the
study was NHS Tertiary care hospitals. After informed consent,
we randomized eligible women in a 1:1:1 ratio (30 participants
in each group) to one of the three treatment groups: (1)
Intervention, consisting of 60 days of the app delivering
mindfulness meditation content (in addition to usual care); (2)
Active control, consisting of 60 days of the app delivering
progressive muscle relaxation content (in addition to usual care);
and (3) Treatment as usual consisting of usual care. See Figure
1 for a flow chart of the study.
Outcomes
Feasibility Outcomes Collected From Participants
Several parameters were collected regarding the participants
(Textbox 1).
Participant Focus Groups
Usability and integration into clinical practice were explored in
two postintervention focus groups at each recruiting site: one
for each app group. All participants allocated to each app group
were invited to a session to take place in a private room at or
near the clinic they were recruited from. We aimed to recruit
approximately 15 app participants from the study participants.
We offered a telephone interview as an alternative to any
participant who was unable to attend their focus group.
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Discussions were structured around the app System Usability
Scale (SUS) and additional questionnaire, and were expected
to take two hours to complete. Discussions were recorded and
literal themes on integration and usability will be evaluated for
in-depth information. This information will be considered, as
well as adherence to the app, as an indirect measure of
acceptability. We will determine primary and secondary
outcomes of interest, from the perspective of patients, for a
full-scale trial. This aim will involve asking participants who
were randomized to the app groups to discuss and prioritize
outcomes. Obstacles to recruitment will also be explored.
Health Care Practitioner Focus Groups
The health care practitioners that were involved with the trial
were invited to attend focus groups. A purpose-made topic guide
was used to structure focus groups with service providers, which
were held in private rooms at the university or clinic, and based
on the Normalization Process Theory toolkit [34] and Diffusion
of Innovations Theory [35]. Topics were used as a prompt by
the facilitator to identify any emergent or residual problems that
might act as a barrier to use and effectiveness of the app in the
RCT, and implementation into practice.
The service providers were asked to consider their role and their
organization, to suggest and discuss any issues related to
integration, and to also suggest potential solutions (unlike
conventional qualitative research focus groups). Discussions
considered relative advantage versus existing practices,
compatibility with existing practices, simplicity and ease of
integration, trialability and reinvention of the process, feedback
(eg, can clinicians see that patients benefit?), and peer-to-peer
networking. We will use our findings to develop our integration
approach to be further explored in the subsequent full trial.
Obstacles to recruitment will also be explored.
Clinical Outcomes
Clinical outcomes measures have been selected based on the
findings of our systematic review [11] and for their relevance
to women with CPP. All scales are validated. We will use the
clinical outcomes listed in Textbox 2.
All clinical outcomes were self-reports completed by study
participants at baseline, 60 days, 3 months, and 6 months
postrandomization (Multimedia Appendix 2).
Figure 1. Participant flow showing eligibility, enrolment, randomization and follow-up.
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Textbox 1. Feasibility outcomes collected from patients
• Time taken to recruit all patients for the study (measured from the day recruitment opens until the day the 90th patient was randomized).
• Estimates to be used for the sample size calculation of the full-scale randmoized control trial:
• The estimated standard deviation for pain acceptance (as measured by the Chronic Pain Acceptance Questionnaire [CPAQ-8] [32])
• The dropout rate defined by the proportion of participants who never return or answer a follow-up questionnaire at 6 months postrandomization
• The proportion of participants who do not return a follow-up questionnaire, but do answer the questionnaire by phone at 6 months
postrandomization
• Patient adherence to app use will be investigated using the following outcomes:
• Number of days (within the first 60 days from randomization) a patient has used the app. The definition of app use was originally defined
as having completed 50% of a session. This definition was changed to 90% of a session during the trial (see Multimedia Appendix 1).
• Whether the patient has used the app on 22 or more days within the first 60 days following randomization
• Number of weeks (within the first 8 weeks from randomization) during which a patient has used the app on three or more days
• Whether the patient has used the app on three or more days in 6 or more weeks (within the first 8 weeks from randomization)
• Whether the patient has used the app on 22 or more days within the first 60 days from randomization, and used the app on three or more
days in 6 or more weeks within the first 8 weeks from randomization
• Usability of the app will be measured by:
• The System Usability Scale [33]
• A purpose-made nonvalidated questionnaire (Multimedia Appendix 2) developed from patient and public involvement discussion and
exploring the issues this group suggested women with chronic pelvic pain might have when using the particular app chosen. For example,
we consider its modular format as well as the fit within daily activities, as we had been told from public and patient engagement work that
this might be a problem for working women.
Textbox 2. Clinical outcomes
• Pain acceptance score (as measured by the Chronic Pain Acceptance Questionnaire [CPAQ-8] [32])
• Quality of life score, Physical Functioning subscale (as measured by the RAND 36-item Short Form health survey [SF-36] [36])
• Quality of life score, Social Functioning subscale (as measured by the RAND SF-36)
• Quality of life score, Pain subscale (as measured by the RAND SF-36)
• Quality of life score, General Health subscale (as measured by the RAND SF-36)
• Depression score (as measured by the Hospital Anxiety and Depression Scale [HADS] [37])
• Anxiety score (as measured by the HADS)
• Mindfulness score (as measured by the Cognitive and Mindfulness Scale - Revised [CAMS-R] [38])
• Pain related disability score (as measured by the Chronic Pain Grade [CPG] disability subscale [39])
• Self-efficacy score (as measured by the Pain Self-Efficacy Questionnaire [PSEQ] [40])
• Sexual Health Outcomes score (as measured by Sexual Health Outcomes in Women Questionnaire [SHOW-Q] [41])
• Subjective outcome score (as measured by Measure Yourself Medical Outcome Profile [MYMOP] [42])
Recruitment
Informed Consent Procedures
Women were made aware of the study by health care
professionals and through promotional materials. Potentially
eligible patients received the Patient Information Sheet (PIS)
and were given adequate time (at least 24 hours) to consider the
trial. Health care professionals and researchers screened
eligibility at the time of outpatient clinic visits before offering
participation. Women not interested or not eligible were
recorded in a screening log. Eligible patients who were seen in
clinics other than pelvic pain and endometriosis clinics were
given the PIS and contact details for the researcher so they could
benefit from participating in MEMPHIS, if they so wished.
Randomization Procedures
After providing informed consent, patients were randomized
(maintaining full allocation concealment) in a 1:1:1 ratio to one
of the three treatment groups, using permuted blocks without
stratification. Block sizes were 27, 30, and 33. Randomization
was performed using a centralized Internet service, hosted by
the Pragmatic Clinical Trials Unit at Queen Mary University of
London.
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Blinding Following Allocation to Study Arm
The participant and recruiting staff were aware of allocation to
either the Treatment as usual group or one of the app groups.
The participant and recruiting staff were, however, blinded to
allocation to the Intervention or Active Control app groups.
To preserve blinding of participants within the two app arms of
the study, each group used the same app and hearing instructions
for the same duration, delivered by the same narrator. Only the
content of the instructions differed. In addition, the PIS and
consent forms did not explicitly refer to “mindfulness
meditation” or “progressive muscle relaxation.”
Data on whether any unblinding occured with recruiting staff,
or if participants were aware of their allocation, were collected
immediately after randomization and after 6 months,
respectively. Statisticians will be blinded to individual treatment
allocations until required for the final analysis.
Interventions
The researchers encouraged participants to aim to use the app
they were randomized to daily, for as many sessions as they felt
comfortable with.
The Active Intervention: Mindfulness Meditation App
The meditation content was delivered via a structured and
progressive course, layering in new techniques and concepts
over successive sessions. The course was created and narrated
by a former monk, Andy Puddicombe, drawing on a secularized
version of the techniques he was taught over 10 years in
monasteries around the world.
The techniques used in the Intervention are shown in Table 1.
The first 30 days covered basic techniques, assuming no
previous experience of meditation. The second 30 days focused
specifically on the use of these techniques with respect to pain.
The duration of individual sessions built over time. Days 1-10
involved 10 minutes/day, days 11-20 involved 15 minutes/day,
and days 21-60 involved 20 minutes/day. Headspace collected
data on adherence to the active intervention.
The Active Control App and the Treatment As Usual
Group
The Active Control group used the same app, but the app was
configured so that they heard a series of nonmeditative
progressive muscle relaxation instructions, also narrated by
Andy Puddicombe. These sessions were identical every day,
except that their duration increased to mirror the increasing
duration of the meditation content being listened to by the
Intervention group.
In this way, both Intervention and Active Control groups used
the same app, and hearing instructions for the same duration,
delivered by the same narrator. Only the content of the
instructions differed. Headspace collected data on adherence to
the active control.
The control group consisting of treatment as usual (watch and
wait, medication, and/or surgery) was included to investigate
if any app intervention makes a difference to well-being and to
ascertain dropout rates for the full-scale trial in patients who
perceive that they are receiving no intervention.
Schedule of Assessment
Health outcome measures were collected at baseline and
immediately after the intervention at 60 days, 3 months, and 6
months. The time points were chosen to obtain information
close to finishing the intervention to assess immediate effects,
at a mid-point, and after 6 months to assess longer-term effects.
App satisfaction/usability measures were collected immediately
after the intervention (at 60 days) from app participants. Patients
entered the data on paper questionnaires, which was transferred
into a purpose-built electronic database. Data management will
be carried out using OpenClinica Enterprise v3.12.2.
As an incentive to complete and return the patient
questionnaires, a £5 shopping voucher was sent in the post with
each follow-up questionnaire, alongside a stamped addressed
envelope. In the case that a questionnaire was not received,
participants were sent a text message reminder. Nonresponders
were then contacted by telephone in order to collect a subset of
the questionnaire.
Participants allocated to the app groups were asked for
permission to elaborate on the open comment boxes about app
satisfaction, and discuss and prioritize clinical outcomes in two
focus groups. The focus groups were held after the 6-month
follow-up point finished. If participants were unable to attend
a focus group, they were given the option to take part in a phone
interview.
Statistical Analyses
A full analysis plan can be found in Multimedia Appendix 3.
Thirty participants were recruited to each of the three treatment
groups, giving a total of 90 participants. As this is a feasibility
study, we have not performed a sample size calculation based
upon the power to detect a significant treatment effect on a
clinical outcome. However, 90 participants should provide a
reliable estimate for the standard deviation (SD) of the primary
clinical outcome (likely to be pain acceptance) [43,44], which
can be used to inform the sample size calculation of the main
trial. Statistical analyses will be carried out using Stata 14.
Table 1. Meditation content over 60-day progressive course.
Techniques involvedSeries
Open monitoring, body scan, breath as anchorTake 10/Foundation 1 (first 10 days)
As above, plus intention and altruismFoundation 2 (days 11-20)
As above, plus integration of mindfulness with daily activitiesFoundation 3 (days 21-30)
As above, plus visualization and enquiry (insight/Tibetan Vipassana)Pain series (days, 31-60)
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Baseline variables will be summarized for each treatment group
using descriptive statistics.
Analysis of Feasibility Outcomes
The time taken to recruit all patients for the study and the
number of participants recruited per month will be presented.
An estimate of the SD of pain acceptance (CPAQ-8) in each
treatment group at each follow up time point (60 days, 3 months,
and 6 months) will be presented.
The proportion of patients in each treatment group who returned
data at each follow-up time point (60 days, 3 months, and 6
months postrandomization) will be summarized. Summaries of
baseline variables will be presented separately for patients who
did and did not return data at each at the 6-month time point.
Patient adherence outcomes and outcomes measuring usability
of the app will be summarized separately for the intervention
and active control treatment groups using descriptive statistics.
Analysis of Clinical Outcomes
For each clinical outcome we will present the number of patients
in each treatment group with an observed outcome at each
follow-up time point, and the mean (SD) in each treatment group
at each follow-up time point. Estimates of treatment effect and
95% confidence intervals will be presented comparing the
intervention group (mindfulness meditation app) to the control
(treatment as usual) group, the intervention group to the active
control (progressive muscle relaxation app) group, and the active
control group to the control (treatment as usual) group.
Outcomes will be analyzed using linear mixed-effects models
with outcome measurement (at three follow-up time points) as
the dependent variable. The model will include fixed time
effects, a fixed effect for treatment, time treatment interactions
for 3-month and 6-month follow-up time points, and an
unstructured correlation matrix for the residuals [45]. The model
will include a baseline measure of the outcome as a covariate,
assuming a linear relationship between baseline and outcome
[46]. The model will be fitted using restricted maximum
likelihood. Patient data will be analyzed according to the
treatment group to which they were randomized
(intention-to-treat). All patients with an observed outcome for
at least one of the three follow-up time points (60 days, 3
months, or 6 months) will be included in the analysis [47]. If
there are missing values for baseline measures of a clinical
outcome, they will be replaced by the mean of the observed
baseline values for all participants in all treatment arms (mean
imputation) [48].
Qualitative Analysis
We will undertake a literal thematic analysis of the data from
the focus group discussions to help us understand usability and
implementation of, and response to, the intervention and research
protocols [49,50] rather than developing or testing theory [51].
Features of app use and implementation issues will be
summarized in a table of app features. For example, we will
populate the row labelled modular design with comments on
this specific feature. Columns of this table will represent more
granular themes.
Results
Recruitment for MEMPHIS took place between May 2016 and
September 2016. The study was closed March 2017 and the
report was submitted to the NIHR on October 26, 2017.
Discussion
There are currently no rigorous RCTs that test mindfulness
meditation interventions as a therapy for any chronic pain
syndrome, including CPP. A previous systematic review [52]
and our systematic review [11] identified no RCTs on
mindfulness meditation in CPP. However, recent pilot studies
[12,14,15] demonstrate promising outcomes and open the door
for a large well-designed study with meaningful outcome
measures. Given that psychological approaches, when combined
with traditional therapies such as surgery, improve outcomes
in CPP [7], mindfulness meditation is worthy of further
investigation.
The intervention under investigation is novel in that it makes
use of mindfulness meditation techniques as a treatment for
CPP and it delivers this by means of a smartphone app (rather
than traditional face-to-face therapy). Web- and
smartphone-based health apps are a burgeoning field and offer
the nonmedical population assistance in self-diagnosis,
monitoring of long term medical conditions, or learning healthy
behaviors. In the pain field alone, 279 smartphone apps were
available for download in 2014, but these were simplistic, had
unverified efficacy, and lacked the involvement of health care
professionals in their development [53]. In our experience, no
apps are currently incorporated into widespread routine clinical
practice in CPP management. MEMPHIS presents a valuable
opportunity to create a partnership between app development
and health care professionals.
Not all patients with CPP would be expected to be highly
confident in using smartphones and mobile technology,
especially since women who are not usually using apps were
recruited. Part of our data analysis, collected through focus
groups, is directed towards the acceptability and usability of
the app and will be valuable for any researcher planning future
trials of smartphone technology in clinical interventions.
Given the ubiquity of the app, greater compliance with treatment
and less wastage from patients not attending appointments may
be expected. The use of the app in local primary, secondary,
and tertiary care settings would be introduced in collaboration
with general practitioner commissioning groups through local
guidelines and protocols. Finally, if the app is shown to be
effective in a full-scale trial, there would be benefit from
studying how to extend the app to other pain conditions, such
as headaches, back pain, and irritable bowel syndrome, in which
face-to-face delivery of mindfulness meditation has had positive
effects [9].
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